Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-bay crawled time : 20:00 save search
Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock
Published: 2024-02-21 (Crawled : 20:00) - biospace.com/
TNON | $0.75 12K
|
|
| O: 3.69%
H: 2.68%
C: 0.89%
million series
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
Published: 2024-01-09 (Crawled : 20:00) - biospace.com/
DGX | $128.165 1.79% 500K
|
Health Services
|
| O: 0.28%
H: 0.65%
C: 0.08%
disease technology diagnostics
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
Published: 2023-11-01 (Crawled : 20:00) - biospace.com/
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -1.12%
H: 1.26%
C: -1.57%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: 0.22%
H: 1.92%
C: 1.78%
pipeline
Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business Update
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
RIGL | $1.055 0.48% 260K
|
Health Technology
|
| O: -0.53%
H: 6.9%
C: 3.99%
conference report business update financial results
Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
ANIX | News | $3.1 18K
|
Health Technology
|
| O: -0.63%
H: 2.52%
C: -0.32%
conference cancer research
Ivonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
SMMT A | $3.445 -1.85% 450K
|
Health Technology
|
| O: -0.78%
H: 2.09%
C: 1.57%
presentation
Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results
Published: 2023-10-25 (Crawled : 20:00) - biospace.com/
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 2.71%
H: 0.62%
C: -5.77%
genetic reach solutions results study
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
Published: 2023-10-04 (Crawled : 20:00) - biospace.com/
ACET | $1.915 -5.43% 270K
|
Health Technology
|
| O: -0.77%
H: 0.78%
C: 0.0%
conference presentation cancer therapeutics molecular
Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test
Published: 2023-05-09 (Crawled : 20:00) - biospace.com/
GH M | $16.305 -2.19% 380K
|
Health Services
|
| O: -1.1%
H: 4.06%
C: 3.09%
disease test health blood week study
Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 20:00) - biospace.com/
GRTS | $0.7477 0.54% 600K
|
Health Technology
|
| O: 1.98%
H: 4.85%
C: -7.77%
vaccine cancer meeting
Arcellx to Participate at the Canaccord Genuity 2023 Horizons in Oncology Virtual Conference
Published: 2023-04-13 (Crawled : 20:00) - biospace.com/
ACLX | $51.62 -5.28% 250K
|
|
| O: 0.85%
H: 4.25%
C: 2.81%
conference
Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution
Published: 2023-01-09 (Crawled : 20:00) - biospace.com/
CALA | $0.04 5.3K
|
Health Technology
|
| O: -79.56%
H: 6.76%
C: -10.8%
approval
Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition
Published: 2022-12-12 (Crawled : 20:00) - biospace.com/
CRVS | $1.405 -0.36% 28K
|
Health Technology
|
| O: 6.8%
H: 0.91%
C: -9.11%
cpi-818 pharmaceuticals meeting trial phase 1
IDEAYA Biosciences Announces Submission of IND Application to the U.S. FDA for PARG Development Candidate IDE161
Published: 2022-12-12 (Crawled : 20:00) - biospace.com/
IDYA | $37.06 -1.49% 250K
|
Health Technology
|
| O: 0.18%
H: 3.14%
C: 0.95%
ide161 fda candidate application submission
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
Published: 2022-12-01 (Crawled : 20:00) - biospace.com/
CDNA | $8.105 0.43% 130K
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.85%
lung study
Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
Published: 2022-11-01 (Crawled : 20:00) - biospace.com/
A | $133.2 0.57% 390K
|
Health Technology
|
| O: 0.83%
H: 1.33%
C: 1.0%
year financial results
BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial
Published: 2022-07-26 (Crawled : 20:00) - biospace.com/
BBIO | $24.55 -1.6% 790K
|
Health Technology
|
| O: 8.43%
H: 0.0%
C: -22.32%
pharma children trial positive results achondroplasia
Better Therapeutics Announces Publication of the Rationale, Design and Baseline Characteristics Manuscript for Type 2 Diabetes Pivotal Trial of BT-001, a Novel Prescription Digital Therapy, in Clinical Cardiology
Published: 2022-07-11 (Crawled : 20:00) - biospace.com/
BTTX | $0.009 180K
|
|
| O: 5.68%
H: 5.91%
C: -3.23%
bt-001 trial therapeutics diabetes cardiology publication
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’S VT1021 in GBM AGILE Trial
Published: 2022-07-06 (Crawled : 20:00) - biospace.com/
BHVN | News 0 d | $39.335 -6.7% 1.2M
|
Health Technology
|
| O: -0.01%
H: 0.26%
C: -0.26%
vt1021 trial
Adverum Biotechnologies Presents Research Pipeline Data Supporting Utility of its Proprietary Platform and AAV.7m8 Capsid in Ocular Gene Therapy
Published: 2022-05-19 (Crawled : 20:00) - biospace.com/
ADVM | $11.205 0.49% 31K
|
Health Technology
|
| O: 2.6%
H: 0.57%
C: -0.08%
research ocular therapy platform
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.